Group One Trading’s NxStage Medical Inc. NXTM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-3,800
| Closed | -$109K | – | 5732 |
|
|
2018
Q4 | $109K | Sell |
3,800
-1,200
| -24% | -$34.1K | ﹤0.01% | 3115 |
|
|
2018
Q3 | $139K | Buy |
5,000
+2,500
| +100% | +$70.3K | ﹤0.01% | 3279 |
|
|
2018
Q2 | $70K | Sell |
2,500
-3,400
| -58% | -$91.2K | ﹤0.01% | 3771 |
|
|
2018
Q1 | $147K | Buy |
5,900
+500
| +9% | +$12.2K | ﹤0.01% | 3005 |
|
|
2017
Q4 | $131K | Buy |
5,400
+2,800
| +108% | +$73.8K | ﹤0.01% | 3201 |
|
|
2017
Q3 | $72K | Sell |
2,600
-7,400
| -74% | -$197K | ﹤0.01% | 3437 |
|
|
2017
Q2 | $251K | Buy |
+10,000
| New | +$248K | ﹤0.01% | 2473 |
|
|
2015
Q3 | – | Sell |
-17,600
| Closed | -$251K | – | 5422 |
|
|
2015
Q2 | $251K | Buy |
+17,600
| New | +$298K | ﹤0.01% | 2368 |
|
|
2014
Q2 | – | Sell |
-1,200
| Closed | -$15K | – | 5679 |
|
|
2014
Q1 | $15K | Sell |
1,200
-800
| -40% | -$10.4K | ﹤0.01% | 4418 |
|
|
2013
Q4 | $20K | Buy |
+2,000
| New | +$22.7K | ﹤0.01% | 4247 |
|
|
2013
Q3 | – | Sell |
-1,200
| Closed | -$17K | – | 5814 |
|
|
2013
Q2 | $17K | Buy |
+1,200
| New | +$15.1K | ﹤0.01% | 4182 |
|
Other funds holding NXTM
Group One Trading's NXTM Position: Q1 2019 in Review
Group One Trading sold out of NxStage Medical Inc. (NXTM) in Q1 2019, closing a stake of 1,322 shares — an estimated $38K sold.
Group One Trading first reported a position in NXTM in Q3 2013 and held it in 16 quarters. The position peaked at $492K in Q3 2015. 1 fund tracked by Wall St. Rank holds NXTM as of Q1 2019.
- Group One Trading reported no remaining NxStage Medical Inc. position as of Q1 2019 after selling out during the quarter.
- Group One Trading sold 1,322 NxStage Medical Inc. shares in Q1 2019, an estimated $38K.
- Group One Trading first reported a position in NxStage Medical Inc. in Q3 2013 and held it in 16 quarters.
- Group One Trading's NxStage Medical Inc. position peaked at $492K in Q3 2015.
- 1 fund tracked by Wall St. Rank held NxStage Medical Inc. as of Q1 2019.
Based on Group One Trading's 13F filing for Q1 2019, filed 13 May 2019.